Showing results (21-30 of 87) with videos related to

Sort By:
Pageof 9
The American Journal of Pathology|February 2, 2011
The IL-27 receptor has biphasic effects in crescentic glomerulonephritis mediated through Th1 responsesShaun A Summers, Richard K S Phoon, Joshua D Ooi, et al.
Nephrology (Carlton, Vic.)|June 6, 2015
Programmed death 1 and its ligands do not limit experimental foreign antigen-induced immune complex glomerulonephritisJoshua D Ooi, Ming Li, Katerina Kourkoutzelos, et al.
Journal of the American Society of Nephrology : JASN|June 12, 2016
CD8+ T Cells Effect Glomerular Injury in Experimental Anti-Myeloperoxidase GNJanet Chang, Peter Eggenhuizen, Kim M O'Sullivan, et al.
Frontiers in Immunology|April 30, 2021
T-Cell Receptor Therapy in the Treatment of Ovarian Cancer: A Mini ReviewJessica W Y Wu, Sudiksha Dand, Lachlan Doig, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 8, 2012
The immunodominant myeloperoxidase T-cell epitope induces local cell-mediated injury in antimyeloperoxidase glomerulonephritisJoshua D Ooi, Janet Chang, Michael J Hickey, et al.
Journal of the American Society of Nephrology : JASN|June 7, 2015
Myeloperoxidase Peptide-Based Nasal Tolerance in Experimental ANCA-Associated GNPoh-Yi Gan, Diana S Y Tan, Joshua D Ooi, et al.
Arthritis and Rheumatism|December 31, 2010
Toll-like receptor 2 induces Th17 myeloperoxidase autoimmunity while Toll-like receptor 9 drives Th1 autoimmunity in murine vasculitisShaun A Summers, Oliver M Steinmetz, Poh-Yi Gan, et al.
Journal of the American Society of Nephrology : JASN|July 25, 2019
Apoptotic Cell-Induced, Antigen-Specific Immunoregulation to Treat Experimental Antimyeloperoxidase GNPoh-Yi Gan, Andrea S Godfrey, Joshua D Ooi, et al.
Cytotherapy|March 6, 2022
Improving cell viability using counterflow centrifugal elutriationAnqi Li, Mehri Barabadi, Hannah McDonald, et al.
Journal of Translational Autoimmunity|September 22, 2025
Regulatory T cell therapy for Sjögren's disease: From pathogenesis to targeted treatmentZhi Feng Sherman Lim, Alberta Y Hoi, Fabien B Vincent, et al.
Pageof 9